CME-certified Webcast of a CCO symposium at SABCS 2019 featuring expert perspectives on evolving strategies for treating HR-positive, HER2-negative advanced breast cancer
CCO faculty Dr. Heather McArthur provides insights on trastuzumab deruxtecan and tucatinib for patients with HER2+ MBC who have progressed on standard-of-care HER2-targeted therapies
From Clinical Care Options, view this CME-certified video featuring expert perspectives on treatment of patients with myeloproliferative neoplasms
CME-certified Webcast of a CCO symposium at SNO 2019 featuring expert perspectives on current optimal use of TKIs for the treatment of GBM
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.